Anika Therapeutics (ANIK) Insider Trading & Ownership → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free ANIK Stock Alerts $25.84 +0.41 (+1.61%) (As of 05:21 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Anika Therapeutics (NASDAQ:ANIK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.85%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$541,545.50Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$85,200.00 Get ANIK Insider Trade Alerts Want to know when executives and insiders are buying or selling Anika Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ANIK Insider Buying and Selling by Quarter Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Anika Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/11/2022David ColleranEVPBuy1,500$21.37$32,055.00 3/14/2022David ColleranEVPBuy1,500$26.65$39,975.00 3/11/2022Cheryl R BlanchardCEOBuy8,100$25.57$207,117.00 3/11/2022Jeffery S ThompsonDirectorBuy2,000$24.66$49,320.00 3/11/2022Michael L LevitzCFOBuy4,000$24.62$98,480.00 8/11/2021Michael L LevitzCFOBuy2,850$40.21$114,598.50 5/12/2021Raymond J LandDirectorSell2,000$42.60$85,200.00 (Data available from 1/1/2013 forward) ANIK Insider Trading Activity - Frequently Asked Questions Who is on Anika Therapeutics's Insider Roster? The list of insiders at Anika Therapeutics includes Cheryl R Blanchard, David Colleran, Jeffery S Thompson, Michael L Levitz, and Raymond J Land. Learn more on insiders at ANIK. What percentage of Anika Therapeutics stock is owned by insiders? 5.85% of Anika Therapeutics stock is owned by insiders. Learn more on ANIK's insider holdings. Which Anika Therapeutics insiders have been buying company stock? The following insider purchased ANIK shares in the last 24 months: David Colleran ($32,055.00). How much insider buying is happening at Anika Therapeutics? Insiders have purchased a total of 1,500 ANIK shares in the last 24 months for a total of $32,055.00 bought. More Insider Trading Tools from MarketBeat Related Companies: OSUR Insider Transactions CERS Insider Transactions UTMD Insider Transactions ATRI Insider Transactions SRDX Insider Transactions NPCE Insider Transactions BVS Insider Transactions CVRX Insider Transactions TCMD Insider Transactions PLSE Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:ANIK) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.